The pathoetiology of neurofibromatosis 1

American Journal of Pathology

Volumn 178, Issue 5, 2011, Pages 1932-1939

  Jouhilahti, Eeva Mari ^a   Peltonen, Sirkku ^b   Heape, Anthony M ^c   Peltonen, Juha ^a,b  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; MESSENGER RNA; NEUROFIBROMIN; RAS PROTEIN;

ADIPOCYTE; ASTROCYTOMA; CELL SUBPOPULATION; CELL TYPE; CHROMOSOME 17Q; CUTANEOUS NEUROFIBROMA; DIFFERENTIAL DIAGNOSIS; DNA METHYLATION; EPITHELIUM CELL; EXON; FIBROBLAST; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HAPLOINSUFFICIENCY; HUMAN; JUVENILE MYELOMONOCYTIC LEUKEMIA; MAST CELL; MUTATIONAL ANALYSIS; NERVE CELL; NEUROFIBROMA; NEUROFIBROMATOSIS; NONHUMAN; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN TARGETING; RNA DEGRADATION; RNA PROCESSING; SCHWANN CELL; SHORT STATURE; SHORT SURVEY; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

EID: 79959209917     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2010.12.056     Document Type: Short Survey

References (89)

1. Huson S, Compston D, Clark P, Harper P: A genetic study of von Recklinghausen neurofibromatosis in south east Wales, I: prevalence, fitness, mutation rate, and effect of parental transmission on severity. J Med Genet 1989, 26:704-711
2. Lammert M, Friedman J, Kluwe L, Mautner V: Prevalence of neurofibromatosis 1 in German children at elementary school enrollment. Arch Dermatol 2005, 141:71-74 (Pubitemid 40144442)
3. Stumpf D, Alksne J, Annegers J, Brown S, Conneally P, Housman D, Leppert M, Miller J, Moss M, Pileggi A, Rapin I, Strohman R, Swanson L, Zimmerman A:Neurofibromatosis: conference statement: National Institutes of Health Consensus Development Conference. Arch Neurol 1988, 45:575-578
4. Huson SM: The neurofibromatosis: classification, clinical features and genetic counselling. In: Neurofibromatoses. Edited by D Kaufmann. Basel, Karger, 2008, pp 1-20
5. Ferner R: The neurofibromatoses. Pract Neurol 2010, 10:82-93
6. Evans D, Baser M, McGaughran J, Sharif S, Howard E, Moran A: Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet 2002, 39:311-314 (Pubitemid 34526349)
7. Bollag G, McCormick F, Clark R: Characterization of full-length neurofibromin: tubulin inhibits Ras GAP activity. EMBO J 1993, 12: 1923-1927 (Pubitemid 23157708)
8. Legius E, Marchuk D, Collins F, Glover T: Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nat Genet 1993, 3:122-126 (Pubitemid 23079793)
9. Upadhyaya M: NF1 gene structure and NF1 genotype/phenotype correlations. In: Neurofibromatoses. Edited by D Kaufmann. Basel, Karger, 2008, pp 46-62
10. Brannan C, Perkins A, Vogel K, Ratner N, Nordlund M, Reid S, Buchberg A, Jenkins N, Parada L, Copeland N: Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev 1994, 8:1019-1029 (Pubitemid 24145666)
11. Jacks T, Shih T, Schmitt E, Bronson R, Bernards A, Weinberg R: Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nat Genet 1994, 7:353-361 (Pubitemid 24204410)
12. Jadayel D, Fain P, Upadhyaya M, Ponder M, Huson S, Carey J, Fryer A, Mathew C, Barker D, Ponder B: Paternal origin of new mutations in von Recklinghausen neurofibromatosis. Nature 1990, 343:558-559
13. Upadhyaya M, Ruggieri M, Maynard J, Osborn M, Hartog C, Mudd S, Penttinen M, Cordeiro I, Ponder M, Ponder B, Krawczak M, Cooper D: Gross deletions of the neurofibromatosis type 1 (NF1) gene are predominantly of maternal origin and commonly associated with a learning disability, dysmorphic features and developmental delay. Hum Genet 1998, 102:591-597 (Pubitemid 28282590)
14. De Raedt T, Brems H, Lopez-Correa C, Vermeesch J, Marynen P, Legius E: Genomic organization and evolution of the NF1 microdeletion region. Genomics 2004, 84:346-360 (Pubitemid 38834172)
15. Messiaen L, Wimmer K: NF1 mutational spectrum. In: Neurofibromatoses. Edited by D Kaufmann. Basel, Karger, 2008, pp 63-77
16. Messiaen L, Callens T, Mortier G, Beysen D, Vandenbroucke I, Van Roy N, Speleman F, Paepe A: Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Hum Mutat 2000, 15:541-555 (Pubitemid 30368440)
17. Brems H, Chmara M, Sahbatou M, Denayer E, Taniguchi K, Kato R, Somers R, Messiaen L, De Schepper S, Fryns J, Cools J, Marynen P, Thomas G, Yoshimura A, Legius E: Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. Nat Genet 2007, 39:1120-1126 (Pubitemid 47340658)
18. Messiaen L, Yao S, Brems H, Callens T, Sathienkijkanchai A, Denayer E, et al: Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome. JAMA 2009, 302:2111-2118
19. Hermonen J, Hirvonen O, Ylä-Outinen H, Lakkakorpi J, Björkstrand A, Laurikainen L, Kallioinen M, Oikarinen A, Peltonen S, Peltonen J: Neurofibromin: expression by normal human keratinocytes in vivo and in vitro and in epidermal malignancies. Lab Invest 1995, 73:221-228
20. Bonneau F, D'Angelo I, Welti S, Stier G, Ylänne J, Scheffzek K: Expression, purification and preliminary crystallographic characterization of a novel segment from the neurofibromatosis type 1 protein. Acta Crystallogr D Biol Crystallogr 2004, 60:2364-2367 (Pubitemid 41327660)
21. Ballester R, Marchuk D, Boguski M, Saulino A, Letcher R, Wigler M, Collins F: The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell 1990, 63:851-859 (Pubitemid 120035058)
22. Martin G, Viskochil D, Bollag G, McCabe P, Crosier W, Haubruck H, Conroy L, Clark R, O'Connell P, Cawthon R: The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 1990, 63:843-849 (Pubitemid 120035057)
23. Xu G, Lin B, Tanaka K, Dunn D, Wood D, Gesteland R, White R, Weiss R, Tamanoi F: The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae. Cell 1990, 63:835-841 (Pubitemid 120035056)
24. Le L, Parada L: Tumor microenvironment and neurofibromatosis type I: connecting the GAPs. Oncogene 2007, 26:4609-4616
25. Tidyman W, Rauen K: The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation. Curr Opin Genet Dev 2009, 19:230-236
26. Denayer E, de Ravel T, Legius E: Clinical and molecular aspects of RAS related disorders. J Med Genet 2008, 45:695-703
27. Stevenson DA, Swensen JJ, Viskochil DH: Neurofibromatosis type 1 and other syndromes of the Ras pathway. In: Neurofibromatoses. Edited by D Kaufmann. Basel, Karger, 2008, pp 32-45
28. Spurlock G, Bennett E, Chuzhanova N, Thomas N, Jim H, Side L, Davies S, Haan E, Kerr B, Huson S, Upadhyaya M: SPRED1 mutations (Legius syndrome): another clinically useful genotype for dissecting the neurofibromatosis type 1 phenotype. J Med Genet 2009, 46:431-437
29. Descheemaeker M, Roelandts K, De Raedt T, Brems H, Fryns J, Legius E: Intelligence in individuals with a neurofibromatosis type 1 microdeletion. Am J Med Genet A 2004, 131:325-326
30. Venturin M, Guarnieri P, Natacci F, Stabile M, Tenconi R, Clementi M, Hernandez C, Thompson P, Upadhyaya M, Larizza L, Riva P: Mental retardation and cardiovascular malformations in NF1 microdeleted patients point to candidate genes in 17q11.2. J Med Genet 2004, 41:35-41 (Pubitemid 38125685)
31. Upadhyaya M, Huson S, Davies M, Thomas N, Chuzhanova N, Giovannini S, Evans D, Howard E, Kerr B, Griffiths S, Consoli C, Side L, Adams D, Pierpont M, Hachen R, Barnicoat A, Li H, Wallace P, Van Biervliet J, Stevenson D, Viskochil D, Baralle D, Haan E, Riccardi V, Turnpenny P, Lazaro C, Messiaen L: An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c. 2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation. Am J Hum Genet 2007, 80: 140-151 (Pubitemid 46047657)
32. Maertens O, Brems H, Vandesompele J, De Raedt T, Heyns I, Rosenbaum T, De Schepper S, De Paepe A, Mortier G, Janssens S, Speleman F, Legius E, Messiaen L: Comprehensive NF1 screening on cultured Schwann cells from neurofibromas. Hum Mutat 2006, 27: 1030-1040 (Pubitemid 44454056)
33. De Raedt T, Maertens O, Serra E, Legius E: Somatic NF1 mutations in tumors and other tissue. In: Neurofibromatoses. Edited by D Kaufmann. Basel, Karger, 2008, pp 143-153
34. Peltonen J, Peltonen S: Composition of neurofibromas, NF1 expression, and comparison of normal and NF1 haploinsufficient cells. In: Neurofibromatoses. Ed by D Kaufmann. Basel, Karger, 2008, pp 129-142
35. Cichowski K, Santiago S, Jardim M, Johnson B, Jacks T: Dynamic regulation of the Ras pathway via proteolysis of the NF1 tumor suppressor. Genes Dev 2003, 17:449-454 (Pubitemid 36258759)
36. Fishbein L, Eady B, Sanek N, Muir D, Wallace M: Analysis of somatic NF1 promoter methylation in plexiform neurofibromas and Schwann cells. Cancer Genet Cytogenet 2005, 157:181-186 (Pubitemid 40255202)
37. Harder A, Rosche M, Reuss D, Holtkamp N, Uhlmann K, Friedrich R, Mautner V, von Deimling A: Methylation analysis of the neurofibromatosis type 1 (NF1) promoter in peripheral nerve sheath tumours. Eur J Cancer 2004, 40:2820-2828 (Pubitemid 39574737)
38. Lee T, Friedman J: Analysis of NF1 transcriptional regulatory elements. Am J Med Genet A 2005, 137:130-135 (Pubitemid 41262678)
39. Wrabetz L, Feltri M, Kim H, Daston M, Kamholz J, Scherer S, Ratner N: Regulation of neurofibromin expression in rat sciatic nerve and cultured Schwann cells. Glia 1995, 15:22-32
40. Ylä-Outinen H, Aaltonen V, Björkstrand A, Hirvonen O, Lakkakorpi J, Vähä-Kreula M, Laato M, Peltonen J: Upregulation of tumor suppressor protein neurofibromin in normal human wound healing and in vitro evidence for platelet derived growth factor (PDGF) and transforming growth factor-beta1 (TGF-β1) elicited increase in neurofibromin mRNA steady-state levels in dermal fibroblasts. J Invest Dermatol 1998, 110:232-237 (Pubitemid 28144597)
41. Atit R, Crowe M, Greenhalgh D, Wenstrup R, Ratner N: The Nf1 tumor suppressor regulates mouse skin wound healing, fibroblast proliferation, and collagen deposited by fibroblasts. J Invest Dermatol 1999, 112:835-842 (Pubitemid 29277981)
42. Kuorilehto T, Ekholm E, Nissinen M, Hietaniemi K, Hiltunen A, Paavolainen P, Penttinen R, Peltonen J: NF1 gene expression in mouse fracture healing and in experimental rat pseudarthrosis. J Histochem Cytochem 2006, 54:363-370 (Pubitemid 43291281)
43. Hirvonen O, Lakkakorpi J, Aaltonen V, Hirvonen H, Rossi M, Karvonen S, Ylä-Outinen H, Kalimo H, Peltonen J: Developmental regulation of NF1 tumor suppressor gene in human peripheral nerve. J Neurocytol 1998, 27:939-952 (Pubitemid 29522757)
44. Kuorilehto T, Nissinen M, Koivunen J, Benson M, Peltonen J: NF1 tumor suppressor protein and mRNA in skeletal tissues of developing and adult normal mouse and NF1-deficient embryos. J Bone Miner Res 2004, 19:983-989 (Pubitemid 41103455)
45. Griesser J, Kaufmann D, Maier B, Mailhammer R, Kuehl P, Krone W: Post-transcriptional regulation of neurofibromin level in cultured human melanocytes in response to growth factors. J Invest Dermatol 1997, 108:275-280 (Pubitemid 27116223)
46. Nishi T, Lee P, Oka K, Levin V, Tanase S, Morino Y, Saya H: Differential expression of two types of the neurofibromatosis type 1 (NF1) gene transcripts related to neuronal differentiation. Oncogene 1991, 6:1555-1559 (Pubitemid 21924257)
47. Gutmann D, Geist R, Rose K, Wright D: Expression of two new protein isoforms of the neurofibromatosis type 1 gene product, neurofibromin, in muscle tissues. Dev Dyn 1995, 202:302-311
48. Kaufmann D, Müller R, Kenner O, Leistner W, Hein C, Vogel W, Bartelt B: The N-terminal splice product NF1-10a-2 of the NF1 gene codes for a transmembrane segment. Biochem Biophys Res Commun 2002, 294:496-503 (Pubitemid 34694121)
49. Vandenbroucke I, Vandesompele J, De Paepe A, Messiaen L: Quantification of NF1 transcripts reveals novel highly expressed splice variants. FEBS Lett 2002, 522:71-76 (Pubitemid 34722500)
50. Baralle M, Skoko N, Knezevich A, De Conti L, Motti D, Bhuvanagiri M, Baralle D, Buratti E, Baralle F: NF1 mRNA biogenesis: effect of the genomic milieu in splicing regulation of the NF1 exon 37 region. FEBS Lett 2006, 580:4449-4456 (Pubitemid 44118266)
51. Haeussler J, Haeusler J, Striebel A, Assum G, Vogel W, Furneaux H, Krone W: Tumor antigen HuR binds specifically to one of five protein-binding segments in the 3′-untranslated region of the neurofibromin messenger RNA. Biochem Biophys Res Commun 2000, 267:726-732 (Pubitemid 30099391)
52. Ylä-Outinen H, Koivunen J, Nissinen M, Björkstrand A, Paloniemi M, Korkiamäki T, Peltonen S, Karvonen S, Peltonen J: NF1 tumor suppressor mRNA is targeted to the cell-cell contact zone in Ca(2+)-induced keratinocyte differentiation. Lab Invest 2002, 82: 353-361
53. Pummi K, Ylä-Outinen H, Peltonen J: Oscillation and rapid changes of NF1 mRNA steady-state levels in cultured human keratinocytes. Arch Dermatol Res 2000, 292:422-424 (Pubitemid 30618110)
54. Kaufmann D, Bartelt B, Hoffmeyer S, Müller R: Posttranslational regulation of neurofibromin content in melanocytes of neurofibromatosis type 1 patients. Arch Dermatol Res 1999, 291:312-317 (Pubitemid 29281319)
55. Korkiamäki T, Ylä-Outinen H, Leinonen P, Koivunen J, Peltonen J: The effect of extracellular calcium concentration on calcium-mediated cell signaling in NF1 tumor suppressor-deficient keratinocytes. Arch Dermatol Res 2005, 296:465-472 (Pubitemid 40487358)
56. Mangoura D, Sun Y, Li C, Singh D, Gutmann D, Flores A, Ahmed M, Vallianatos G: Phosphorylation of neurofibromin by PKC is a possible molecular switch in EGF receptor signaling in neural cells. Oncogene 2006, 25:735-745 (Pubitemid 43214700)
57. Izawa I, Tamaki N, Saya H: Phosphorylation of neurofibromatosis type 1 gene product (neurofibromin) by cAMP-dependent protein kinase. FEBS Lett 1996, 382:53-59 (Pubitemid 26092233)
58. De Schepper S, Boucneau J, Westbroek W, Mommaas M, Onderwater J, Messiaen L, Naeyaert J, Lambert J: Neurofibromatosis type 1 protein and amyloid precursor protein interact in normal human melanocytes and colocalize with melanosomes. J Invest Dermatol 2006, 126:653-659 (Pubitemid 43255656)
59. Koivunen J, Ylä-Outinen H, Korkiamäki T, Karvonen S, Pöyhönen M, Laato M, Karvonen J, Peltonen S, Peltonen J: New function for NF1 tumor suppressor. J Invest Dermatol 2000, 114:473-479 (Pubitemid 30415332)
60. Hsueh Y, Roberts A, Volta M, Sheng M, Roberts R: Bipartite interaction between neurofibromatosis type I protein (neurofibromin) and syndecan transmembrane heparan sulfate proteoglycans. J Neurosci 2001, 21:3764-3770 (Pubitemid 32466468)
61. Gregory P, Gutmann D, Mitchell A, Park S, Boguski M, Jacks T, Wood D, Jove R, Collins F: Neurofibromatosis type 1 gene product (neurofibromin) associates with microtubules. Somat Cell Mol Genet 1993, 19:265-274 (Pubitemid 23216308)
62. Li C, Cheng Y, Gutmann D, Mangoura D: Differential localization of the neurofibromatosis 1 (NF1) gene product, neurofibromin, with the F-actin or microtubule cytoskeleton during differentiation of telencephalic neurons. Brain Res Dev Brain Res 2001, 130:231-248 (Pubitemid 33000087)
63. Gubin MM, Calaluce R, Davis JW, Magee JD, Strouse CS, Shaw DP, Ma L, Brown A, Hoffman T, Rold TL, Atasoy U: Overexpression of the RNA binding protein HuR impairs tumor growth in triple negative breast cancer associated with deficient angiogenesis. Cell Cycle 2010, 9:3337-3346
64. Chai G, Liu N, Ma J, Li H, Oblinger J, Prahalad A, Gong M, Chang L, Wallace M, Muir D, Guha A, Phipps R, Hock J, Yu X: MicroRNA-10b regulates tumorigenesis in neurofibromatosis type 1. Cancer Sci 2010101:1997-2004
65. Peltonen S, Aaltonen V, Peltonen J: Neurofibromatosis 1. In: Encyclopedia of Cancer, second edition. Edited by M Schwab. Heidelberg, Springer, 2009, pp 2061-2063
66. Knudson AJ: Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 1971, 68:820-823
67. Jouhilahti E-M, Peltonen S, Callens T, Jokinen E, Heape A, Messiaen L, Peltonen J: The development of the cutaneous neurofibromas. Am J Pathol 2011, 178:500-505
68. De Raedt T, Maertens O, Chmara M, Brems H, Heyns I, Sciot R, Majounie E, Upadhyaya M, De Schepper S, Speleman F, Messiaen L, Vermeesch J, Legius E: Somatic loss of wild type NF1 allele in neurofibromas: comparison of NF1 microdeletion and non-microdeletion patients. Genes Chromosomes Cancer 2006, 45:893-904 (Pubitemid 44360177)
69. Visnapuu V, Peltonen S, Ellilä T, Kerosuo E, Väänänen K, Happonen R, Peltonen J: Periapical cemental dysplasia is common in women with NF1. Eur J Med Genet 2007, 50:274-280 (Pubitemid 47058416)
70. Alivuotila L, Hakokari J, Visnapuu V, Korpijaakko-Huuhka A, Aaltonen O, Happonen R, Peltonen S, Peltonen J: Speech characteristics in neurofibromatosis type 1. Am J Med Genet A 2010, 152A:42-51
71. Stevenson D, Zhou H, Ashrafi S, Messiaen L, Carey J, D'Astous J, Santora S, Viskochil D: Double inactivation of NF1 in tibial pseudarthrosis. Am J Hum Genet 2006, 79:143-148 (Pubitemid 43927385)
72. De Schepper S, Maertens O, Callens T, Naeyaert J, Lambert J, Messiaen L: Somatic mutation analysis in NF1 café au lait spots reveals two NF1 hits in the melanocytes. J Invest Dermatol 2008, 128:1050-1053 (Pubitemid 351374293)
73. De Schepper S, Boucneau J, Vander Haeghen Y, Messiaen L, Naeyaert J, Lambert J: Café-au-lait spots in neurofibromatosis type 1 and in healthy control individuals: hyperpigmentation of a different kind? Arch Dermatol Res 2006, 297:439-449
74. Brems H, Park C, Maertens O, Pemov A, Messiaen L, Messia L, Upadhyaya M, Claes K, Beert E, Peeters K, Mautner V, Sloan J, Yao L, Lee C, Sciot R, De Smet L, Legius E, Stewart D: Glomus tumors in neurofibromatosis type 1: genetic, functional, and clinical evidence of a novel association. Cancer Res 2009, 69:7393-7401
75. Stewart D, Sloan J, Yao L, Mannes A, Moshyedi A, Lee C, Sciot R, De Smet L, Mautner V, Legius E: Diagnosis, management, and complications of glomus tumours of the digits in neurofibromatosis type 1. J Med Genet 2010, 47:525-532
76. Serra E, Rosenbaum T, Winner U, Aledo R, Ars E, Estivill X, Lenard H, Lázaro C: Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations. Hum Mol Genet 2000, 9:3055-3064 (Pubitemid 32000779)
77. Zhu Y, Ghosh P, Charnay P, Burns D, Parada L: Neurofibromas in NF1: Schwann cell origin and role of tumor environment. Science 2002, 296:920-922 (Pubitemid 34464899)
78. Riccardi V: The genetic predisposition to and histogenesis of neurofibromas and neurofibrosarcoma in neurofibromatosis type 1. Neurosurg Focus 2007, 22:E3
79. Peltonen J, Jaakkola S, Lebwohl M, Renvall S, Risteli L, Virtanen I, Uitto J: Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis. Lab Invest 1988, 59:760-771 (Pubitemid 19019457)
80. Peltonen J, Penttinen R, Larjava H, Aho H: Collagens in neurofibromas and neurofibroma cell cultures. Ann N Y Acad Sci 1986, 486: 260-270 (Pubitemid 17027505)
81. Wu J, Williams J, Rizvi T, Kordich J, Witte D, Meijer D, Stemmer- Rachamimov A, Cancelas J, Ratner N: Plexiform and dermal neurofibromas and pigmentation are caused by Nf1 loss in desert hedgehog-expressing cells. Cancer Cell 2008, 13:105-116 (Pubitemid 351163159)
82. +/- and c-kit-dependent bone marrow. Cell 2008, 135:437-448
83. Yang F, Ingram D, Chen S, Hingtgen C, Ratner N, Monk K, Clegg T, White H, Mead L, Wenning M, Williams D, Kapur R, Atkinson S, Clapp D: Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/- mast cells. J Clin Invest 2003, 112:1851-1861 (Pubitemid 38063708)
84. Olsson Y: Mast cells in human peripheral nerve. Acta Neurol Scand 1971, 47:357-368
85. Evans D, Komminoth P, Scheihauer B, Peltonen J: Neurofibromatosis type 1. In: WHO Classification of Tumours. Pathology & Genetics: Tumours of Endocrine Organs. Chapter 5: Inherited Tumour Syndromes. Edited by R DeLellis, R Lioyd, P Heitz, C Eng. Lyon, IARC Press, 2004, pp 243-248
86. Le L, Shipman T, Burns D, Parada L: Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas. Cell Stem Cell 2009, 4:453-463
87. Brohlin M, Mahay D, Novikov L, Terenghi G, Wiberg M, Shawcross S, Novikova L: Characterisation of human mesenchymal stem cells following differentiation into Schwann cell-like cells. Neurosci Res 2009, 64:41-49
88. Amoh Y, Li L, Campillo R, Kawahara K, Katsuoka K, Penman S, Hoffman R: Implanted hair follicle stem cells form Schwann cells that support repair of severed peripheral nerves. Proc Natl Acad Sci U S A 2005, 102:17734-17738 (Pubitemid 41803566)
89. Karvonen S, Kallioinen M, Ylä-Outinen H, Pöyhönen M, Oikarinen A, Peltonen J: Occult neurofibroma and increased S100 protein in the skin of patients with neurofibromatosis type 1: new insight to the etiopathomechanism of neurofibromas. Arch Dermatol 2000, 136: 1207-1209